Laseroptek Co., Ltd.
Financials
Valuation Metrics
Laseroptek Co., Ltd.'s Market Cap is ₩336B. At end of 2025 it was ₩769B. Ranked #1959 of 2,436 in KR market (top 80%), #1225 of 1,649 on KOSDAQ (top 74%), #81 of 96 in Health Care Equipment & Services (top 84%) by Market Cap.
Investment Metrics(as of 2026-08-04)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 33.55B KRW | KR#1,959/2,436 Sec#81/96 |
| Revenue | 26.79B KRW | KR#2,068/2,436 Sec#68/96 |
| Net Income | -9.20B KRW | KR—/2,436 Sec—/96 |
| Total Assets | 35.30B KRW | KR#2,295/2,436 Sec#85/96 |
| Net Assets | 20.88B KRW | KR#2,270/2,436 Sec#88/96 |
| Employees | 79 | KR#1,799/2,436 Sec#69/96 |
| Value | ||
| P/B | 1.61x | KR#1,882/2,436 Sec#66/96 |
| P/S | 1.25x | KR#1,591/2,436 Sec#40/96 |
| FCF Yield | -21.16% | KR—/2,436 Sec—/96 |
| Profitability | ||
| ROE | -44.05% | KR#2,247/2,436 Sec#83/96 |
| ROA | -26.05% | KR#2,265/2,436 Sec#82/96 |
| Op. Margin | -43.75% | KR#2,224/2,436 Sec#77/96 |
| Revenue Growth | 20.81% | KR#625/2,436 Sec#29/96 |
| Earnings Growth | -4517.73% | KR#1,742/2,436 Sec#61/96 |
| Financial Health | ||
| Debt Ratio | 169.08% | KR#1,433/2,436 Sec#72/96 |
| Total Debt | 0 KRW | KR—/2,436 Sec—/96 |
| FCF | -7.10B KRW | KR#1,599/2,436 Sec#55/96 |
| Cash | 5.77B KRW | KR#1,932/2,436 Sec#68/96 |
| Current Ratio | 2.19x | KR#856/2,436 Sec#46/96 |
| Performance | ||
| 1Y Return | -65.18% | KR#2,269/2,436 Sec#88/96 |
| 1M Return | -31.62% | KR#2,326/2,436 Sec#92/96 |
| From 52W High | -72.07% | KR#2,123/2,436 Sec#78/96 |
| 1Y MDD | -69.28% | KR#1,875/2,436 Sec#67/96 |
| Trading | ||
| Volume | 124,253 shares | KR#1,193/2,436 Sec#44/96 |
| Foreign Own. | 1.53% | KR—/2,436 Sec—/96 |
| Per Share | ||
| EPS | -696 KRW | KR—/2,436 Sec—/96 |
| BPS | 1,577 KRW | KR#2,142/2,436 Sec#74/96 |
Company Info
LASEROPTEK, established in 2000, specializes in developing and manufacturing medical devices based on laser original technology, and was listed on KOSDAQ in 2024. Initially, it developed laser products for semiconductor and automobile manufacturing processes, but later expanded into skin aesthetics and disease treatment fields following the growth of the beauty device market. The company entered the domestic laser beauty device market in 2005 with LOTUS and HELIOS, achieving overseas expansion in 2009 with US FDA and Europe CE certifications. LASEROPTEK is headquartered in Seongnam-si, Gyeonggi-do.